Diurnal rhythms in the human urine metabolome during sleep and total sleep deprivation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Giskeødegård, Guro F ^a,b   Davies, Sarah K ^c,d   Revell, Victoria L ^c   Keun, Hector ^d   Skene, Debra J ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; CREATININE; DIMETHYLAMINE; FORMIC ACID DERIVATIVE; TAURINE;

ADOLESCENT; ADULT; CIRCADIAN RHYTHM; HUMAN; MALE; METABOLOME; METABOLOMICS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; SLEEP; SLEEP DEPRIVATION; TIME FACTOR; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; CIRCADIAN RHYTHM; CITRATES; CREATININE; DIMETHYLAMINES; FORMATES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; METABOLOMICS; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; SLEEP; SLEEP DEPRIVATION; TAURINE; TIME FACTORS; YOUNG ADULT;

EID: 84943649257     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14843     Document Type: Article

References (43)

1. Moolenaar, S. H., Engelke, U. F. H. & Wevers, R. A. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann Clin Biochem 40, 16-24 (2003).
2. Holmes, E. et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453, 396-400 (2008).
3. Maitre, L. et al. Urinary metabolic profiles in early pregnancy are associated with preterm birth and fetal growth restriction in the Rhea mother-child cohort study. BMC Med 12, 110 (2014).
4. Saude, E. J., Adamko, D., Rowe, B. H., Marrie, T. & Sykes, B. D. Variation of metabolites in normal human urine. Metabolomics 3, 439-451 (2007).
5. Slupsky, C. M. et al. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79, 6995-7004 (2007).
6. 1H NMR spectroscopy-based metabolic phenotyping studies. Anal Chem 79, 5204-5211 (2007).
7. Maret, S. et al. Homer1a is a core brain molecular correlate of sleep loss. Proc Natl Acad Sci USA 104, 20090-20095 (2007).
8. Ackermann, K. et al. Effect of sleep deprivation on rhythms of clock gene expression and melatonin in humans. Chronobiol Int 30, 901-909 (2013).
9. Archer, S. N. et al. Mistimed sleep disrupts circadian regulation of the human transcriptome. Proc Natl Acad Sci USA 111, E682-691 (2014).
10. Bass, J. & Turek, F. W. Sleepless in America: a pathway to obesity and the metabolic syndrome? Arch Intern Med 165, 15-16 (2005).
11. Spiegel, K., Knutson, K., Leproult, R., Tasali, E. & Van Cauter, E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99, 2008-2019 (2005).
12. Scheer, F. A. J. L., Hilton, M. F., Mantzoros, C. S. & Shea, S. A. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA 106, 4453-4458 (2009).
13. Cappuccio, F. P., Cooper, D., D'Elia, L., Strazzullo, P. & Miller, M. A. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 32, 1484-1492 (2011).
14. Davies, S. K. et al. Effect of sleep deprivation on the human metabolome. Proc Natl Acad Sci USA 111, 10761-10766 (2014).
15. Weljie, A. M. et al. Oxalic acid and diacylglycerol 36:3 are cross-species markers of sleep debt. Proc Natl Acad Sci USA 112, 2569-2574 (2015).
16. Ackermann, K. et al. Diurnal rhythms in blood cell populations and the effect of acute sleep deprivation in healthy young men. Sleep 35, 933-940, doi: 10.5665/sleep.1954 (2012).
17. Dona, A. C. et al. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal Chem 86, 9887-9894 (2014).
18. Veselkov, K. A. et al. Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery. Anal Chem 81, 56-66 (2009).
19. 1H NMR metabonomics. Anal Chem 78, 4281-4290 (2006).
20. Wishart, D. S. et al. HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res 41, D801-807 (2013).
21. Diaz, S. O. et al. Following healthy pregnancy by nuclear magnetic resonance (NMR) metabolic profiling of human urine. J Proteome Res 12, 969-979 (2013).
22. Appiah-Amponsah, E. et al. Identification of 4-deoxythreonic acid present in human urine using HPLC and NMR techniques. J Pharm Biomed Anal 50, 878-885 (2009).
23. Rezzi, S. et al. Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res 6, 4469-4477 (2007).
24. Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R. & Nicholson, J. K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 106, 14728-14733 (2009).
25. 1H NMR data sets. Anal Chem 77, 1282-1289 (2005).
26. Barantin, L., Le Pape, A. & Akoka, S. A new method for absolute quantitation of MRS metabolites. Magn Reson Med 38, 179-182 (1997).
27. Meijers, B. K. I. & Evenepoel, P. The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant 26, 759-761 (2011).
28. Monti, J. M. Serotonin control of sleep-wake behavior. Sleep Med Rev 15, 269-281 (2011).
29. Dallmann, R., Viola, A. U., Tarokh, L., Cajochen, C. & Brown, S. A. The human circadian metabolome. Proc Natl Acad Sci USA 109, 2625-2629 (2012).
30. Vanholder, R., Schepers, E., Pletinck, A., Nagler, E. V. & Glorieux, G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol 25, 1897-1907 (2014).
31. Duranton, F. et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 23, 1258-1270 (2012).
32. Barreto, F. C. et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 4, 1551-1558 (2009).
33. Taki, K., Tsuruta, Y. & Niwa, T. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients. Am J Nephrol 27, 30-35 (2007).
34. Fujii, H., Nakai, K. & Fukagawa, M. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Ther Apher Dial 15, 125-128 (2011).
35. Tumur, Z. & Niwa, T. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells. Am J Nephrol 29, 551-557 (2009).
36. Katayose, Y. et al. Metabolic rate and fuel utilization during sleep assessed by whole-body indirect calorimetry. Metab Clin Exp 58, 920-926 (2009).
37. Sharma, S. & Kavuru, M. Sleep and metabolism: an overview. Int J Endocrinol 2010 (2010).
38. Jia, F. et al. Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus. The Journal of neuroscience: the official journal of the Society for Neuroscience 28, 106-115, doi: 10.1523/JNEUROSCI.3996-07.2008 (2008).
39. Coulon, P., Budde, T. & Pape, H. C. The sleep relay-the role of the thalamus in central and decentral sleep regulation. Pflugers Archiv: European journal of physiology 463, 53-71, doi: 10.1007/s00424-011-1014-6 (2012).
40. Altamura, C., Maes, M., Dai, J. & Meltzer, H. Y. Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 5, Suppl, 71-75 (1995).
41. Perry, T. L. et al. Hereditary mental depression and Parkinsonism with taurine deficiency. Archives of neurology 32, 108-113 (1975).
42. Bennett, B. J. et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab 17, 49-60 (2013).
43. O'Sullivan, A., Gibney, M. J. & Brennan, L. Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr 93, 314-321 (2011).